Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv

被引:63
|
作者
Morlock, GP [1 ]
Plikaytis, BB [1 ]
Crawford, JT [1 ]
机构
[1] Ctr Dis Control & Prevent, TB Mycobacteriol Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
关键词
D O I
10.1128/AAC.44.12.3298-3301.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to rifampin in Mycobacterium tuberculosis results from mutations in the gene coding for the beta subunit of RNA polymerase (rpoB), At least 95% of rifampin-resistant isolates have mutations in rpoB, and the mutations are clustered in a small region. About 40 distinct point mutations and in-frame insertions and deletions in rpoB have been identified, but point mutations in two codons, those coding for Ser,,, and His,,,, are seen in about 70% of rifampin-resistant clinical isolates, with Ser(531)-t-Leu (TCG-to TGG) mutations being by far the most common. To explore this phenomenon, we isolated independent, spontaneous, rifampin-resistant mutant versions of well-characterized M, tuberculosis laboratory strain H37Rv by plating 100 separate cultures, derived from a single low-density inoculum, onto rifampin containing medium. Rifampin-resistant mutants were obtained from 64 of these cultures. Although we anticipated that the various point mutations would occur with approximately equal frequencies, sequencing the rpoB gene from one colony per plate revealed that 39 (60.9%) were Ser(531) to Leu. We conclude that, for unknown reasons, the associated rpoB mutation occurs at a substantially higher rate than other rpoB mutations. This higher mutation rate may contribute to the high percentage of this mutation seen in clinical isolates.
引用
收藏
页码:3298 / 3301
页数:4
相关论文
共 50 条
  • [1] IN VITRO ACTIVITY OF RIFAMPIN AGAINST H37RV STRAIN OF MYCOBACTERIUM TUBERCULOSIS
    HOBBY, GL
    LENERT, TF
    MAIERENG.J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1969, 99 (03): : 453 - &
  • [2] Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants
    Huitric, Emma
    Werngren, Jim
    Jureen, Pontus
    Hoffner, Sven
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2860 - 2862
  • [3] In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants
    Hillemann, Doris
    Ruesch-Gerdes, Sabine
    Richter, Elvira
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 800 - 801
  • [4] TRYPTOPHAN UPTAKE BY MYCOBACTERIUM-TUBERCULOSIS H37RV - EFFECT OF RIFAMPIN AND ETHAMBUTOL
    SUNDARAM, KS
    VENKITASUBRAMANIAN, TA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (05) : 726 - 730
  • [5] STUDIES OF THE CATALASE ACTIVITY OF MYCOBACTERIUM TUBERCULOSIS STRAIN H37RV
    TYSAROWSKI, W
    KWIEK, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1959, 80 (02): : 257 - 258
  • [6] Evaluation of the expression of cytokines and chemokines in macrophages in response to rifampin-monoresistant Mycobacterium tuberculosis and H37Rv strain
    Ravan, Parvaneh
    Sattari, Taher Nejad
    Siadat, Seyed Davar
    Vaziri, Farzam
    CYTOKINE, 2019, 115 : 127 - 134
  • [7] SULFATIDE-III OF MYCOBACTERIUM-TUBERCULOSIS STRAIN H37RV
    GOREN, MB
    DAS, BC
    BROKL, O
    NOUVEAU JOURNAL DE CHIMIE-NEW JOURNAL OF CHEMISTRY, 1978, 2 (04): : 379 - 384
  • [8] POLYNUCLEOTIDE PHOSPHORYLASE OF MYCOBACTERIUM TUBERCULOSIS H37RV
    MALATHI, VG
    SIRSI, M
    MALLER, RK
    RAMAKRISHNAN, T
    INDIAN JOURNAL OF BIOCHEMISTRY, 1964, 1 (02): : 71 - +
  • [9] GLUCOSE DISSIMILATION BY MYCOBACTERIUM TUBERCULOSIS H37RV
    INDIRA, M
    RAMAKRISHNAN, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1963, 88 (04): : 509 - &
  • [10] Analysis of the genome of Mycobacterium tuberculosis H37Rv
    Cole, ST
    Barrell, BG
    GENETICS AND TUBERCULOSIS, 1998, 217 : 160 - 177